Compared with aspirin, cilostazol was associated with a higher risk of MALE (sHR 1.45 [95% CI 1.15–1.84]), whereas clopidogrel showed a nonsignificant trend (sHR 1.31 [95% CI 0.99–1.72]).
← all excerpts
Prognostic implications of single antiplatelet therapy in individuals developing diabetic foot disease with concurrent peripheral arterial disease.
1
—
—